Consecutive non-Aspergillus Fungal Invasive Infections in Chronic Granulomatous Disease: Data from the French National Reference Center for Primary ImmunoDeficiencies and literature review.

Date publication

novembre 2025

Journal

Journal of clinical immunology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr FOUYSSAC Fanny

Tous les auteurs :
Lefevre L, Paccoud O, Neven B, Bougnoux ME, Alligon M, Bruneau J, Fischer A, Moshous D, Bustamante J, Picard C, Poiree S, Guery R, Castelle M, Suarez F, Marcais A, Cheminant M, Rouzaud C, Hermoso DG, Salvator H, Catherinot E, Pilmis B, Luca L, Brion JP, Revest M, Gandemer V, Lelievre L, Alvarez M, Conrad A, Fouyssac F, Gaud C, Blumental S, Blanche S, Lortholary O, Mahlaoui N, Lanternier F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41193884

Résumé

Non-Aspergillus invasive fungal infections (NAFI) are increasingly reported in patients with Chronic Granulomatous Disease (CGD), but precise clinical descriptions remain scarce.

Mots clés

Antifungal prophylaxis, Breakthrough, Chronic Granulomatous Disease, Non-Aspergillus invasive fungal infection (NAFI)

Référence

J Clin Immunol. 2025 11 6;45(1):152